# Study of LTC004 in Subjects With Advanced Malignant Tumors

> **NCT05666635** · PHASE1 · UNKNOWN · sponsor: **Letolab** · enrollment: 368 (estimated)

## Conditions studied

- Adult Solid Tumor

## Interventions

- **BIOLOGICAL:** LTC004

## Key facts

- **NCT ID:** NCT05666635
- **Lead sponsor:** Letolab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 368 (ESTIMATED)
- **Last updated:** 2022-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05666635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05666635, "Study of LTC004 in Subjects With Advanced Malignant Tumors". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05666635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*